Current status and future potential role of exemestane in the treatment of early and advanced breast cancer (Review).

International journal of oncology

Volumn 20, Issue 6, 2002, Pages 1283-1288

  Crucitta, Enrico ^a   Fornier, Monica N ^a   Locopo, Nathalia ^a   Silvestris, Nicola ^a   Lorusso, Vito ^a   De Lena, Mario ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; ENZYME INHIBITOR; EXEMESTANE;

BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; METASTASIS; MORTALITY; REVIEW;

ANDROSTADIENES; ANTINEOPLASTIC AGENTS; AROMATASE INHIBITORS; BREAST NEOPLASMS; CLINICAL TRIALS; ENZYME INHIBITORS; FEMALE; HUMANS; NEOPLASM METASTASIS;

MLCS; MLOWN;

EID: 0036615820     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.20.6.1283     Document Type: Review

References (29)